Home Cart 0 Sign in  
X

[ CAS No. 90560-10-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 90560-10-4
Chemical Structure| 90560-10-4
Chemical Structure| 90560-10-4
Structure of 90560-10-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 90560-10-4 ]

Related Doc. of [ 90560-10-4 ]

Alternatived Products of [ 90560-10-4 ]

Product Details of [ 90560-10-4 ]

CAS No. :90560-10-4 MDL No. :MFCD13181215
Formula : C9H8OS Boiling Point : -
Linear Structure Formula :- InChI Key :WGDVDMKNSDCNGB-UHFFFAOYSA-N
M.W : 164.22 Pubchem ID :13634237
Synonyms :

Calculated chemistry of [ 90560-10-4 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.11
Num. rotatable bonds : 1
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 48.32
TPSA : 37.47 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.31
Log Po/w (XLOGP3) : 2.91
Log Po/w (WLOGP) : 2.91
Log Po/w (MLOGP) : 2.16
Log Po/w (SILICOS-IT) : 3.65
Consensus Log Po/w : 2.79

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.23
Solubility : 0.0965 mg/ml ; 0.000588 mol/l
Class : Soluble
Log S (Ali) : -3.36
Solubility : 0.0721 mg/ml ; 0.000439 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.46
Solubility : 0.0569 mg/ml ; 0.000347 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.87

Safety of [ 90560-10-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 90560-10-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 90560-10-4 ]
  • Downstream synthetic route of [ 90560-10-4 ]

[ 90560-10-4 ] Synthesis Path-Upstream   1~21

  • 1
  • [ 96803-85-9 ]
  • [ 90560-10-4 ]
YieldReaction ConditionsOperation in experiment
63%
Stage #1: With methanesulfonic acid; Celite In hexane for 1 h; Heating / reflux
Stage #3: at 20℃;
Method B: A solution of the crude 1- (2, 2-diethoxyethylsulfanyl)-3-methoxybenzene (8.27 g, 32.3 mmole) in hexane (100 ml) was added, dropwise, to a solution of [METHANESULFONIC] acid (1.05 [ML,] 1.55 g, 16.1 mmole) in hexane (1000 [ML)] containing 16.5 [G] of celite (2 wt. eq. ). The resultant solution was heated at reflux for one hour. After cooling to room temperature, the reaction was quenched by addition of Et3N (4.5 ml, 3.26 g, 32.3 [MMOLE).] The crude reaction mixture was filtered and the filtrate was concentrated, in vacuo, to give a red oil which was purified by silica gel chromatography. Elution with hexane: [ET20] (98: 2) and evaporation of the appropriate fractions gave 3.35 g (63percent) of a [COLORLESS OIL.APOS;H] NMR [(DMSO-D6)] 8 7.74 [(1 H,] d, [J=8. 7HZ),] 7.56 [(1 H,] d, [J = 2. 3 HZ),] 7.52 [(1 H,] d, [J=5. 3HZ),] 7.33 (1 H, d, J = 5.3Hz), 6.99 (1 H, dd, J = 2.3, 8.7 Hz), 3.81 (3H, s). Anal. Calcd. for [C9HBOS :] C, 65.82 ; H, 4.91 ; S, 19.53. Found: C, 66.01 ; H, 5.00 ; S, 19.40.
52%
Stage #1: With boron trifluoride diethyl etherate In dichloromethane at 20℃; for 0.5 h;
Stage #2: With water; sodium hydrogencarbonate In dichloromethane
Step B: The product from Step A (15.0 g, 58.5 mmol) was dissolved in methylene chloride (125 mL) and the solution was added to a solution of boron trifluoride diethyl etherate (7.86 mL, 62 mmol) in methylene chloride (900 mL) at room temperature under nitrogen. The reaction mixture was stirred for 30 minutes. Saturated sodium bicarbonate solution was added to the mixture until both phases were clear. The organic layer was extracted with methylene chloride twice. The combined organic extracts were dried over sodium sulfate and concentrated to an oil. The oil was purified by column chromatography (100percent hexanes) to give the desired 6-methoxy benzothiophene (5.0 g, 52percent) as a colorless oil: 1H NMR (500 MHz, CDCl3) δ 7.50 (d, J=5.6 Hz, 1H), 7.46 (d, J=8.1 Hz, 1H), 7.3 (d, J=5.6 Hz, 1H), 7.29-7.25 (m, 1H), 6.75 (d, J=7.8 Hz, 1H), 3.96 (s, 3H).
39%
Stage #1: With boron trifluoride diethyl etherate In dichloromethane at 20℃; for 0.5 h;
Stage #2: With sodium hydrogencarbonate In water for 1 h;
A solution of this crude [1- (2, 2-DIETHOXYETHYLSULFANYL)-3-METHOXYBENZENE] (6.41 g, 25 mmole) in [CH2CI2] (50 ml) was added, dropwise, to a solution of boron [TRIFLUORIDE] etherate (3.4 [MI,] 3.81 g, 27 mmole) in CH2CI2 (500 [ML).] The resultant solution was stirred at ambient temperature for an additional 30 minutes. Aqueous saturated NaHCO3 (200 [ML)] was added and the two-phase mixture was stirred for another hour. The layers were separated and the aqueous phase was extracted with CH2CI2 (150 ml). The combined organic extracts were dried over [NA2SO4] and concentrated, in vacuo, to give 4.3 [G] of a red oil which was purified by silica gel chromatography. Elution with hexane: [ET2O] (98: 2) and evaporation of the appropriate fractions gave 1.62 g (39percent) of a colourless oil.
Reference: [1] Patent: WO2003/106462, 2003, A1, . Location in patent: Page 34
[2] Patent: US2006/52378, 2006, A1, . Location in patent: Page/Page column 149
[3] Patent: WO2003/106462, 2003, A1, . Location in patent: Page 34
[4] Patent: WO2005/73206, 2005, A1, . Location in patent: Page/Page column 23-27
[5] Patent: US2009/286863, 2009, A1, . Location in patent: Page/Page column 7-8
[6] Patent: US6756388, 2004, B1, . Location in patent: Page/Page column 51
[7] International Journal of Chemical Kinetics, 2012, vol. 44, # 11, p. 736 - 744,9
[8] Journal of Physical Organic Chemistry, 2012, vol. 25, # 11, p. 925 - 932
  • 2
  • [ 105126-91-8 ]
  • [ 90560-10-4 ]
YieldReaction ConditionsOperation in experiment
61%
Stage #1: With boron trifluoride diethyl etherate In dichloromethane at 0℃; for 0.45 h;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water at 8℃; for 0.0833333 h;
Boron trifluoride etherate (8.15 ml.) dissolved in dry dichloromethane (407 ml.) was stirred rapidly at 0 °C under nitrogen and a solution of (3-methoxyphenylsulphanyl)acetaldehyde (1 1.5 g, 63.10 mmol) in dry dichloromethane (29 ml.) was added dropwise over 25 min. The resultant green solution was stirred for 2 min and then saturated aqueous sodium bicarbonate solution (150 ml.) was added at a rate so as to maintain the temperature <8°C. The reaction mixture was stirred for 5 min and then the layers were separated and the organic layer was washed with saturated aqueous sodium bicarbonate solution (100 ml.) and water (100 mL). The organic phase was dried (MgSO4), and concentrated in vacuo. The product was purified by distillation to afford the title compound as a colourless oil (6.29 g, 61 percent, b.p. 83-88 °C at 16 mBar).
61%
Stage #1: at 8℃; for 0.45 h;
Stage #2: With sodium hydrogencarbonate In dichloromethane; water at 8℃; for 0.0833333 h;
Boron trifluoride etherate (8.15 mL) dissolved in dry dichloromethane (407 mL) was stirred rapidly at 0 C. under nitrogen and a solution of (3-methoxyphenylsulphanyl)acetaldehyde (11.5 g, 63.10 mmol) in dry dichloromethane (29 mL) was added dropwise over 25 min. The resultant green solution was stirred for 2 min and then saturated aqueous sodium bicarbonate solution (150 mL) was added at a rate so as to maintain the temperature <8 C. The reaction mixture was stirred for 5 min and then the layers were separated and the organic layer was washed with saturated aqueous sodium bicarbonate solution (100 mL) and water (100 mL). The organic phase was dried (MgSO4), and concentrated in vacuo. The product was purified by distillation to afford the title compound as a colourless oil (6.29 g, 61percent, b.p. 83-88 C. at 16 mBar).
Reference: [1] Patent: WO2007/39563, 2007, A1, . Location in patent: Page/Page column 21
[2] Patent: US2007/112019, 2007, A1, . Location in patent: Page/Page column 11
  • 3
  • [ 96803-85-9 ]
  • [ 90560-10-4 ]
  • [ 3781-90-6 ]
YieldReaction ConditionsOperation in experiment
16% With boron trifluoride diethyl etherate In dichloromethane at 20℃; Inert atmosphere To the obtained (2,2-diethoxyethyl)(3-methoxyphenyl)sulfane (91, 3.6 g, 14.0 mmol) dissolved in a dichloromethane solution (70 mL) was slowly added trifluoroborane etherate (BF3-Et2O; 1.75 mL, 13.72 mmol) at room temperature under nitrogen, and the reaction mixture was stirred for one hour and neutralized with a sodium bicarbonate solution at room temperature. Organic layer was isolated, organic compounds in water were extracted with dichloromethane, the recovered organic solution was evaporated after a treatment with sodium sulfate, and concentrated under reduced pressure. After concentration, residues were purified by column chromatography to give the target compounds 4-methoxybenzothiophene (92a, 368 mg, 16percent) and 6-methoxybenzothiophene compounds (92b, 1.38 g, 60percent) as transparent liquids.Preparation Example 14-methoxybenzothiophene (92a); 1H NMR (400 MHz, CDCl3) δ 3.95 (s, 3H), 6.74 (d, J=7.6 Hz, 1H), 7.27 (d, J=8.0 Hz, 1H), 7.32 (d, J=5.6 Hz, 1H), 7.46 (dd, J=0.8, 7.2 Hz, 1H), 7.50 (d, J=5.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 55.42, 103.72, 114.76, 120.44, 124.48, 125.15, 130.35, 141.21, 154.93.Preparation Example 26-methoxybenzothiophene (92b); 1H NMR (400 MHz, CDCl3) δ 3.82 (s, 3H), 7.01 (dd, J=8.8, 2.0 Hz, 1H), 7.56 (d, J=2.0 Hz, 2H), 7.82 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 56.0, 105.3, 114.9, 125.1, 131.4, 135.3, 138.9, 144.9, 158.0.
Reference: [1] Helvetica Chimica Acta, 2016, vol. 99, # 5, p. 384 - 392
[2] Patent: US2010/261727, 2010, A1, . Location in patent: Page/Page column 17
[3] Journal of Medicinal Chemistry, 1989, vol. 32, # 12, p. 2548 - 2554
[4] Journal of Organic Chemistry, 1995, vol. 60, # 7, p. 1936 - 1938
[5] Phosphorus, Sulfur and Silicon and the Related Elements, 1994, vol. 96, # 1-4, p. 441 - 444
[6] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 5, p. 759 - 764
[7] Patent: WO2009/5998, 2009, A1, . Location in patent: Page/Page column 177-178
[8] Patent: WO2008/157270, 2008, A1, . Location in patent: Page/Page column 93-94
  • 4
  • [ 98733-08-5 ]
  • [ 90560-10-4 ]
YieldReaction ConditionsOperation in experiment
407 mg With polyphosphoric acid In toluene at 80℃; for 1 h; To a stirred solution of 1 -[(2,2-dimethoxyethyt)sutfanyt]-3-methoxybenzene (1.0 g) in chlorobenzene (40 mL) was added polyphosphoric acid (1.0 g; CASRN: [8017-16-1]; >83percent phosphate (as P205) from Sigma-Aldrich; Order No. 04101) and the mixture was heated to 80CC for 1 h. The mixture was cooled to0°C with an ice-bath and an aqueous solution of sodium hydroxide was addedwith ice bath cooling until pH7 was reached. The mixture was extracted with dichloromethane, the organic phase was dried (sodium sulfate) and the solvent was removed in vacuum. Silicagel chromatography gave 407 mg of the title compound, containing approx. 20percent of a second isomer. This mixture was used for the next step without further purification. 1H-NMR (400 MHz, DMSO-d6), 6 [ppm] = 3.81 (3H), 6.99 (1H), 7.31-7.35 (1H),7.51 (1H), 7.56 (IH), 7.74 (1H). The product contains approx. 20percent of a second isomer.
Reference: [1] Proceedings - Indian Academy of Sciences, Section A, 1951, # 33, p. 35,40
[2] Patent: WO2014/195276, 2014, A1, . Location in patent: Page/Page column 117
[3] Patent: WO2014/198594, 2014, A1, . Location in patent: Page/Page column 113; 114
  • 5
  • [ 15570-12-4 ]
  • [ 2032-35-1 ]
  • [ 90560-10-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2002, vol. 45, # 7, p. 1399 - 1401
[2] Patent: EP2103620, 2009, A1, . Location in patent: Page/Page column 72-73
  • 6
  • [ 102539-79-7 ]
  • [ 90560-10-4 ]
Reference: [1] Patent: WO2018/118838, 2018, A1, . Location in patent: Paragraph 001510; 001513
  • 7
  • [ 96803-64-4 ]
  • [ 90560-10-4 ]
  • [ 3781-90-6 ]
Reference: [1] Patent: WO2004/101545, 2004, A1, . Location in patent: Page 12
  • 8
  • [ 15570-12-4 ]
  • [ 90560-10-4 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 1999, vol. 9, # 5, p. 759 - 764
[2] Journal of Medicinal Chemistry, 1989, vol. 32, # 12, p. 2548 - 2554
[3] European Journal of Medicinal Chemistry, 1986, vol. 21, # 3, p. 223 - 229
[4] International Journal of Chemical Kinetics, 2012, vol. 44, # 11, p. 736 - 744,9
[5] Patent: WO2014/195276, 2014, A1,
[6] Patent: WO2014/198594, 2014, A1,
  • 9
  • [ 15570-12-4 ]
  • [ 96803-85-9 ]
  • [ 2032-35-1 ]
  • [ 90560-10-4 ]
YieldReaction ConditionsOperation in experiment
63% With methanesulfonic acid; trifluoroborane diethyl ether; sodium hydrogencarbonate; potassium carbonate; triethylamine In hexane; dichloromethane; acetone Example (1a)
6-methoxybenzo[b]thiophene
A mixture of 3-methoxybenzenethiol (10 ml, 11.30 g, 80 mmole), K2CO3 (11.15 g, 80 mmole) and bromoacetaldehyde diethyl acetal (12 ml, 15.72 g, 80 mmole) in acetone (100 ml) was stirred at ambient temperature for 16 hours, then filtered.
The filtrate was subsequently concentrated, in vacuo.
The residue obtained was partitioned between H2O (150 ml) and Et2O (150 ml).
The layers were separated and the aqueous phase was extracted with Et2O (150 ml).
The combined organic extracts were washed with 0.5 M KOH (aq), H2O and brine, then dried over Na2SO4 and concentrated, in vacuo, to give 20.4 g of an amber oil which was used directly in the subsequent cyclization without any further purification.
Method A: A solution of this crude 1-(2,2-diethoxyethylsulfanyl)-3-methoxybenzene (6.41 g, 25 mmole) in CH2Cl2 (50 ml) was added, dropwise, to a solution of boron trifluoride etherate (3.4 ml, 3.81 g, 27 mmole) in CH2Cl2 (500 ml).
The resultant solution was stirred at ambient temperature for an additional 30 minutes.
Aqueous saturated NaHCO3 (200 ml) was added and the two-phase mixture was stirred for another hour.
The layers were separated and the aqueous phase was extracted with CH2Cl2 (150 ml).
The combined organic extracts were dried over Na2SO4 and concentrated, in vacuo, to give 4.3 g of a red oil which was purified by silica gel chromatography.
Elution with hexane: Et2O (98:2) and evaporation of the appropriate fractions gave 1.62 g (39percent) of a colourless oil.
Method B: A solution of the crude 1-(2,2-diethoxyethylsulfanyl)-3-methoxybenzene (8.27 g, 32.3 mmole) in hexane (100 ml) was added, dropwise, to a solution of methanesulfonic acid (1.05 ml, 1.55 g, 16.1 mmole) in hexane (1000 ml) containing 16.5 g of celite (2 wt. eq.).
The resultant solution was heated at reflux for one hour.
After cooling to room temperature, the reaction was quenched by addition of Et3N (4.5 ml, 3.26 g, 32.3 mmole).
The crude reaction mixture was filtered and the filtrate was concentrated, in vacuo, to give a red oil which was purified by silica gel chromatography.
Elution with hexane: Et2O (98:2) and evaporation of the appropriate fractions gave 3.35 g (63percent) of a colorless oil. 1H NMR (DMSO-d6) δ7.74 (1H, d, J=8.7 Hz), 7.56 (1H, d, J=2.3 Hz), 7.52 (1H, d, J=5.3 Hz) 7.33 (1H, d, J=5.3 Hz), 6.99 (1H, dd, J=2.3, 8.7 Hz), 3.81 (3H, s). Anal. Calcd. for C9H8OS: C, 65.82; H, 4.91; S, 19.53. Found: C, 66.01; H, 5.00; S, 19.40.
Reference: [1] Patent: US2004/9965, 2004, A1,
  • 10
  • [ 5858-22-0 ]
  • [ 90560-10-4 ]
Reference: [1] Synlett, 2002, # 2, p. 325 - 327
[2] Tetrahedron, 2003, vol. 59, # 26, p. 4767 - 4774
  • 11
  • [ 144-55-8 ]
  • [ 96803-85-9 ]
  • [ 90560-10-4 ]
Reference: [1] Patent: US4668697, 1987, A,
  • 12
  • [ 98733-08-5 ]
  • [ 90560-10-4 ]
  • [ 3781-90-6 ]
Reference: [1] European Journal of Medicinal Chemistry, 1986, vol. 21, # 3, p. 223 - 229
  • 13
  • [ 7465-86-3 ]
  • [ 90560-10-4 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 26, p. 4767 - 4774
[2] Synlett, 2002, # 2, p. 325 - 327
  • 14
  • [ 596805-19-5 ]
  • [ 90560-10-4 ]
Reference: [1] Tetrahedron, 2003, vol. 59, # 26, p. 4767 - 4774
[2] Synlett, 2002, # 2, p. 325 - 327
  • 15
  • [ 15570-12-4 ]
  • [ 90560-10-4 ]
  • [ 3781-90-6 ]
Reference: [1] Helvetica Chimica Acta, 2016, vol. 99, # 5, p. 384 - 392
[2] Patent: WO2008/157270, 2008, A1,
  • 16
  • [ 331-64-6 ]
  • [ 90560-10-4 ]
Reference: [1] Patent: WO2018/118838, 2018, A1,
  • 17
  • [ 187753-62-4 ]
  • [ 90560-10-4 ]
Reference: [1] Patent: WO2018/118838, 2018, A1,
  • 18
  • [ 22546-89-0 ]
  • [ 90560-10-4 ]
Reference: [1] Chemische Berichte, 1959, vol. 92, p. 293,297
  • 19
  • [ 3996-32-5 ]
  • [ 90560-10-4 ]
Reference: [1] Chemische Berichte, 1959, vol. 92, p. 293,297
  • 20
  • [ 86119-84-8 ]
  • [ 98733-08-5 ]
  • [ 90560-10-4 ]
Reference: [1] Proceedings - Indian Academy of Sciences, Section A, 1951, # 33, p. 35,40
  • 21
  • [ 90560-10-4 ]
  • [ 1929-29-9 ]
Reference: [1] Chemische Berichte, 1959, vol. 92, p. 293,297
Same Skeleton Products
Historical Records